FDA Panel Stirs Backlash for SSRI Use During Pregnancy

FDA panel stirs backlash for SSRI use during pregnancy

Today's biotech news includes a mother's perspective on Sarepta's gene therapy halt, an FDA panel made up largely of SSRI skeptics, and more.

FDA SOUNDS THE ALARM ON SSRIS - The HighWire

This week, new FDA Commissioner Dr. Marty Makary hosted an open panel to address the dangers of SSRI medications, particularly for pregnant women, featuring several esteemed physicians who have previously appeared on The HighWire. Hear how the FDA is now pushing for black box warnings on these widely prescribed drugs and calling for radical transparency […]